Testing version — LOERadar is in active testing. Features and data may change.
NEURONTIN (GABAPENTIN) | LOERadar
Not in the current Orange Book — This application is not listed in FDA's current Orange Book data files (no listed patents or exclusivities). Product and approval data shown are from FDA's Drugs@FDA database.
NEURONTIN
NDANot in Orange Book
GABAPENTIN | N021424 | PARKE DAVIS
PTAB Proceedings
No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board
Hatch-Waxman Litigation
No ANDA patent litigation cases (NOS 835) matched from PACER
Citizen Petitions
No FDA citizen petitions matched from Regulations.gov
Products (1)
#001 — 250MG/5ML
▴
SOLUTION; ORAL | Approved: May. 24, 2002
No patent or exclusivity listings for this strength.